Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Collins

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
Vaccine|October 16, 1999
Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterpartsM H Skiadopoulos, T Tao, S R Surman, et al.
Journal of Virology|April 1, 1988
Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infectionM K Spriggs, P L Collins, E Tierney, et al.
Journal of Virology|April 29, 1998
Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzeesS S Whitehead, K Juhasz, C Y Firestone, et al.
Journal of Virology|November 17, 2001
Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cellsA Bukreyev, I M Belyakov, J A Berzofsky, et al.
Virology|July 15, 1986
Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxovirusesM K Spriggs, R A Olmsted, S Venkatesan, et al.
Virology|April 20, 1995
A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genesM Connors, J E Crowe, C Y Firestone, et al.
Pediatrics|July 1, 1992
Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunizationR M Chanock, R H Parrott, M Connors, et al.
Microbial Pathogenesis|July 1, 1990
Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumoniaR Gupta, J W Yewdell, R A Olmsted, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986
Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectorsL A Ball, K K Young, K Anderson, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 8, 1997
Gestational changes in the uterine expression of an inwardly rectifying K+ channel, ROMKD W Lundgren, J J Moore, S M Chang, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Vaccine|October 16, 1999
Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterpartsM H Skiadopoulos, T Tao, S R Surman, et al.
Journal of Virology|April 1, 1988
Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infectionM K Spriggs, P L Collins, E Tierney, et al.
Journal of Virology|April 29, 1998
Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzeesS S Whitehead, K Juhasz, C Y Firestone, et al.
Journal of Virology|November 17, 2001
Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cellsA Bukreyev, I M Belyakov, J A Berzofsky, et al.
Virology|July 15, 1986
Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxovirusesM K Spriggs, R A Olmsted, S Venkatesan, et al.
Virology|April 20, 1995
A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genesM Connors, J E Crowe, C Y Firestone, et al.
Pediatrics|July 1, 1992
Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunizationR M Chanock, R H Parrott, M Connors, et al.
Microbial Pathogenesis|July 1, 1990
Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumoniaR Gupta, J W Yewdell, R A Olmsted, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986
Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectorsL A Ball, K K Young, K Anderson, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 8, 1997
Gestational changes in the uterine expression of an inwardly rectifying K+ channel, ROMKD W Lundgren, J J Moore, S M Chang, et al.
Pageof 16